ReviewClinical Medicine Insights. Oncology2013

Axitinib: a review of its safety and efficacy in the treatment of adults with advanced renal cell carcinoma.

Marine Gross-Goupil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.